MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

MDT

89.1

+0.54%↑

VEEV

283.96

+1.41%↑

A

121.45

+0.27%↑

WBA

11.56

+0.35%↑

HQY

99.61

-3.32%↓

Search

Pacific Biosciences of California Inc

Lezárt

SzektorEgészségügy

1.47 -1.34

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1.41

Maximum

1.49

Fő mutatók

By Trading Economics

Bevétel

-428M

-426M

Értékesítés

-2.1M

37M

Profit margin

-1,146.812

Munkavállalók

575

EBITDA

-420M

-403M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+44% upside

Osztalékok

By Dow Jones

Következő eredményjelentés

2025. aug. 6.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

141M

480M

Előző nyitás

2.81

Előző zárás

1.47

Hangulat hírek alapján

By Acuity

50%

50%

162 / 376 Rangsor szerint Healthcare

Technikai pontszám

By Trading Central

Bizalom

Bullish Evidence

Pacific Biosciences of California Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. júl. 8. 19:37 UTC

Fő piaci mozgatók
Felvásárlások, összeolvadások, átvételek

M3-Brigade Shares Fall on Merger With ReserveOne

2025. júl. 8. 23:45 UTC

Piaci beszéd

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

2025. júl. 8. 23:42 UTC

Piaci beszéd

Nikkei May Rise as Yen Weakens -- Market Talk

2025. júl. 8. 23:27 UTC

Piaci beszéd

Australian REITs Yet to Offer Enough Appeal -- Market Talk

2025. júl. 8. 23:27 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. júl. 8. 23:21 UTC

Piaci beszéd

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

2025. júl. 8. 23:21 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. júl. 8. 22:29 UTC

Felvásárlások, összeolvadások, átvételek

Capricorn to Pay A$1.5 Million in Cash and Shares

2025. júl. 8. 22:28 UTC

Felvásárlások, összeolvadások, átvételek

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

2025. júl. 8. 21:58 UTC

Piaci beszéd

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

2025. júl. 8. 20:50 UTC

Piaci beszéd

Financial Services Roundup: Market Talk

2025. júl. 8. 20:50 UTC

Piaci beszéd

Tech, Media & Telecom Roundup: Market Talk

2025. júl. 8. 20:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. júl. 8. 20:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. júl. 8. 19:53 UTC

Piaci beszéd

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

2025. júl. 8. 19:53 UTC

Piaci beszéd

Market Talk Roundup: Latest on U.S. Politics

2025. júl. 8. 19:45 UTC

Piaci beszéd

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

2025. júl. 8. 19:29 UTC

Piaci beszéd

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

2025. júl. 8. 19:20 UTC

Piaci beszéd

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025. júl. 8. 19:11 UTC

Piaci beszéd

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

2025. júl. 8. 19:01 UTC

Piaci beszéd

Oil Futures Gain With Support From Products -- Market Talk

2025. júl. 8. 18:49 UTC

Eredményjelentés

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

2025. júl. 8. 18:41 UTC

Piaci beszéd

Mexico's Inflation Seen Mixed in June -- Market Talk

2025. júl. 8. 18:38 UTC

Piaci beszéd

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

2025. júl. 8. 18:23 UTC

Piaci beszéd

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

2025. júl. 8. 18:10 UTC

Piaci beszéd

Market Talk Roundup: Latest on U.S. Politics

2025. júl. 8. 18:10 UTC

Piaci beszéd

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

2025. júl. 8. 17:24 UTC

Piaci beszéd

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

2025. júl. 8. 17:06 UTC

Piaci beszéd

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

2025. júl. 8. 16:20 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

Társak összehasonlítása

Árváltozás

Pacific Biosciences of California Inc Előrejelzés

Célár

By TipRanks

44% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 2.16 USD  44%

Magas 3 USD

Alacsony 1.25 USD

8 Wall Street elemző 12 hónapos célárain alapulva a(z)Pacific Biosciences of California Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

8 ratings

5

Vétel

3

Tartás

0

Eladás

Technikai pontszám

By Trading Central

1.13 / N/ATámogatás & ellenállás

Rövid táv

Bullish Evidence

Középtáv

Bearish Evidence

Hosszú táv

Weak Bearish Evidence

Hangulat

By Acuity

162 / 376 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.